11:59 AM EST - NUCRYST Pharmaceuticals Corp. : reported first-quarter net loss of $1.08 million U.S. or $0.06 U.S. per share, compared to a net loss of $2.18 million U.S. or $0.12 U.S. per share last year. Quarterly revenues declined to $4.15 million U.S. from $5.19 million U.S. in the previous year. NUCRYST Pharmaceuticals Corp.
shares T.NCS are trading even at $0.60.
